Position in ASND
as of Mar 31, 2026
· filed May 13, 2026
Position Value
$5,660,838
+$341,993 QoQ
Shares Held
24,749
-0.8% QoQ
Ownership
0.038%
of shares outstanding
% of Portfolio
0.10%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Dec 2024
6 quarters on record
Voting authority
Sole 90%
Shared 0%
None 10%
Common Shares in ASND Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026CAPITAL INTERNATIONAL SARL holds $242,767,746 across 8 Biotechnology names. ASND ranks #6 (2.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
208,882 | $93,274,168 | |
| 2 | ONC |
BeOne Medicines Ltd.
|
173,879 | $51,636,846 | |
| 3 | RPRX |
Royalty Pharma plc
|
1,048,202 | $50,282,249 | |
| 4 | REGN |
Regeneron Pharmaceuticals, Inc.
|
24,602 | $19,008,489 | |
| 5 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
53,349 | $17,651,583 | |
| 6 | ASND |
Ascendis Pharma A/S
This page
|
24,749 | $5,660,838 | |
| 7 | CRSP |
CRISPR Therapeutics AG
|
102,278 | $4,865,364 | |
| 8 | CYTK |
Cytokinetics Inc
|
5,890 | $388,209 |
All Filings in ASND
Export CSV
6 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $5,660,838 | 24,749 | Shares | Defined | 2026-05-13 | |
| 2025-12-31 | $5,318,845 | 24,943 | Shares | Defined | 2026-02-11 | |
| 2025-09-30 | $6,135,674 | 30,862 | Shares | Defined | 2025-11-13 | |
| 2025-06-30 | $4,860,588 | 28,161 | Shares | Defined | 2025-08-13 | |
| 2025-03-31 | $3,956,038 | 25,382 | Shares | Defined | 2025-05-12 | |
| 2024-12-31 | $3,277,372 | 23,806 | Shares | Defined | 2025-02-13 | |
| No filing history on record for this holder in this stock. | ||||||